Comparison of Adalimumab Monotherapy and a Combination With Azathioprine for Patients With Crohn's Disease: A Prospective, Multicenter, Open-Labeled Clinical Trial (DIAMOND Study)

被引：1
|
作者：
Matsumoto, Takayuki
Motoya, Satoshi
Watanabe, Kenji
Hisamatsu, Tadakazu
Nakase, Hiroshi
Yoshimura, Naoki
Ishida, Tetsuya
Kato, Shingo
Nakagawa, Tomoo
Esaki, Motohiro
Nagahori, Masakazu
Matsui, Toshiyuki
Naito, Yuji
Kanai, Takanori
Suzuki, Yasuo
Nojima, Masanori
Watanabe, Mamoru
Hibi, Toshifumi
机构：
来源：
GASTROENTEROLOGY | 2016年 / 150卷 / 04期
关键词：
D O I：
10.1016/S0016-5085(16)30697-7
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
854
引用
收藏
页码：S182 / S182
页数：1
相关论文
共 50 条
  • [21] Withdrawal of thiopurines in Crohn's disease treated with scheduled adalimumab maintenance: a prospective randomised clinical trial (DIAMOND2)
    Hisamatsu, Tadakazu
    Kato, Shingo
    Kunisaki, Reiko
    Matsuura, Minoru
    Nagahori, Masakazu
    Motoya, Satoshi
    Esaki, Motohiro
    Fukata, Norimasa
    Inoue, Satoko
    Sugaya, Takeshi
    Sakuraba, Hirotake
    Hirai, Fumihito
    Watanabe, Kenji
    Kanai, Takanori
    Naganuma, Makoto
    Nakase, Hiroshi
    Suzuki, Yasuo
    Watanabe, Mamoru
    Hibi, Toshifumi
    Nojima, Masanori
    Matsumoto, Takayuki
    Endo, Katsuya
    Hanai, Hiroyuki
    Kobayashi, Taku
    Hiraoka, Sakiko
    Honda, Yutaka
    Inoue, Takuya
    Inoue, Shuji
    Ishida, Tetsuya
    Ito, Hiroaki
    Iwakiri, Ryuichi
    Izumi, Motoyoshi
    Kagaya, Takashi
    Kamata, Noriko
    Naganawa, Yumiko
    Kaneto, Hiroyuki
    Kani, Kazuhito
    Kinjyo, Fukunori
    Yasaka, Hiroki
    Kurahara, Koichi
    Kyouwon, Lee
    Yano, Yutaka
    Matsui, Toshiyuki
    Tanaka, Hiroki
    Munemoto, Yoshinori
    Naito, Yuji
    Nakagawa, Tomoo
    Yokoyama, Yoko
    Nakamura, Shiro
    Okazaki, Kazuichi
    JOURNAL OF GASTROENTEROLOGY, 2019, 54 (10) : 860 - 870
  • [22] Tocilizumab in treatment-naïve patients with Takayasu arteritis: TOCITAKA French prospective multicenter open-labeled trial
    Arsene Mekinian
    David Saadoun
    Eric Vicaut
    Sara Thietart
    Bertrand Lioger
    Patrick Jego
    Alexandre Bleibtreu
    Nicolas Limal
    Jerome Connault
    Jacques-Eric Gottenberg
    Pauline Lhorte
    Jean Pierre Bertola
    Juliette Delforge
    Nicole Ferreira-Maldent
    Antoinette Perlat
    Zohra Talib
    Matthieu Vautier
    Léa Savey
    Isabelle Quiere
    Patrice Cacoub
    Olivier Fain
    Arthritis Research & Therapy, 22
  • [23] Zytux in Refractory Myasthenia Gravis: A Multicenter, Open-Labeled, Clinical Trial Study of Effectiveness and Safety of a Rituximab Biosimilar
    Fatehi, Farzad
    Moradi, Kamyar
    Okhovat, Ali Asghar
    Shojatalab, Ghazaleh
    Sedighi, Behnaz
    Boostani, Reza
    Sarraf, Payam
    Ashtiani, Bahram Haghi
    Ghasemi, Majid
    Moussavi, Soussan
    Anjidani, Nassim
    Nafissi, Shahriar
    FRONTIERS IN NEUROLOGY, 2021, 12
  • [24] ADALIMUMAB FOR PATIENTS WITH CROHN'S DISEASE COMPLICATED BY INTRA-ABDOMINAL ABSCESS: A MULTICENTER PROSPECTIVE, OBSERVATIONAL COHORT STUDY
    de Chambrun, Guillaume Pineton
    Pariente, Benjamin
    Seksik, Philippe
    Altwegg, Romain
    Vuitton, Lucine
    Stefanescu, Carmen
    Nancey, Stephane
    Aubourg, Alexandre
    Serrero, Melanie
    Peyrin-Biroulet, Laurent
    Filippi, Jerome
    Viennot, Stephanie
    Abitbol, Vered
    Boualit, Medina
    Bourreille, Arnaud
    Moreau, Jacques
    Buisson, Anthony
    Roblin, Xavier
    Nachury, Maria
    Zappa, Magaly
    Lambert, Jerome
    Bouhnik, Yoram
    GASTROENTEROLOGY, 2019, 156 (06) : S112 - S112
  • [25] Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: The CHARM trial
    Colombel, Jean-Frederic
    Sandborn, William J.
    Rutgeerts, Paul
    Enns, Robert
    Hanauer, Stephen B.
    Panaccione, Remo
    Schreiber, Stefan
    Byczkowski, Dan
    Li, Ju
    Kent, Jeffrey D.
    Pollack, Paul F.
    GASTROENTEROLOGY, 2007, 132 (01) : 52 - 65
  • [26] Effectiveness and tolerability of methotrexate monotherapy in Crohn's disease patients: A multicenter observational study
    Park, J.
    Jaeyoung, C.
    Jung, P. Soo
    Jun, P. Jae
    Il, K. Tae
    Ho, K. Won
    Hyuk, Y.
    Hee, C. Jae
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1404 - I1404
  • [27] Effectiveness and tolerability of methotrexate monotherapy in Crohn's disease patients: a multicenter observational study
    Park, Jihye
    Chun, Jaeyoung
    Park, Soo Jung
    Park, Jae Jun
    Kim, Tae Il
    Yoon, Hyuk
    Cheon, Jae Hee
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2023, 16
  • [28] Azathioprine dose reduction in inflammatory bowel disease patients on combination therapy: an open-label, prospective and randomised clinical trial
    Roblin, X.
    Boschetti, G.
    Williet, N.
    Nancey, S.
    Marotte, H.
    Berger, A.
    Phelip, J. M.
    Peyrin-Biroulet, L.
    Colombel, J. F.
    Del Tedesco, E.
    Paul, S.
    Flourie, B.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 46 (02) : 142 - 149
  • [29] An open label study of adalimumab in Crohn's disease patients with a loss of response to infliximab
    Anwar, Malik
    O'Sullivan, Maria
    Ryan, Barbara
    Breslin, Niall
    O'Connor, Humphrey
    O'Morain, Colm
    GASTROENTEROLOGY, 2006, 130 (04) : A662 - A662
  • [30] Losartan/hydrochlorothiazide combination vs. high-dose losartan in patients with morning hypertension—a prospective, randomized, open-labeled, parallel-group, multicenter trial
    Tamenobu Ueda
    Hisashi Kai
    Tsutomu Imaizumi
    Hypertension Research, 2012, 35 : 708 - 714
12345